Overview
Olaf Heidenreich practices in Newcastle Upon Tyne, United Kingdom. Mr. Heidenreich is rated as a Distinguished expert by MediFind in the treatment of Leukemia. His top areas of expertise are Leukemia, Childhood Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia (ALL), and Acute Myeloid Leukemia (AML).
His clinical research consists of co-authoring 98 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 83 articles in the study of Leukemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Mr. Heidenreich isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Mr. Heidenreich isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Childhood Acute Myeloid LeukemiaMr. Heidenreich isDistinguished. Learn about Childhood Acute Myeloid Leukemia.
- LeukemiaMr. Heidenreich isDistinguished. Learn about Leukemia.
- Experienced
- Acute Megakaryoblastic LeukemiaMr. Heidenreich isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Myelomonocytic LeukemiaMr. Heidenreich isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Chronic Myelogenous Leukemia (CML)Mr. Heidenreich isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Wilms TumorMr. Heidenreich isExperienced. Learn about Wilms Tumor.